Log in to your Inderes Free account to see all free content on this page.
Xvivo Perfusion
183.60 SEK
+4.44 %
Less than 1K followers
XVIVO
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+4.44 %
-13.23 %
-1.61 %
+6.99 %
+12.02 %
-57.10 %
-22.37 %
-43.16 %
+866.32 %
Xvivo Perfusion operates in the medical technology industry and focuses on the development and manufacturing of systems for organ transplantation and perfusion. Examples of products that the company supplies include cannulas, organ storage and cooling solutions. The company's products are aimed at healthcare institutions and surgeons. Xvivo Perfusion operates globally, was founded in 1998 and is headquartered in Gothenburg, Sweden.
Read moreMarket cap
5.78B SEK
Turnover
14.22M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
24.4.
2026
Interim report Q1'26
27.4.
2026
General meeting '26
14.7.
2026
Interim report Q2'26
All
Webcasts
Press releases
ShowingAll content types
The Nomination Committee of XVIVO Perfusion AB (publ) proposes Emil Billbäck and Anne-Karen Hunt as new members of the Board of Directors
Management change at XVIVO – CFO transitions to new role
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
